Giant Biogene Holding Co., Ltd. (HKG:2367)

Hong Kong · Delayed Price · Currency is HKD

30.78

+0.16 (0.52%)

Jul 31, 2026, 4:08 PM HKT

Giant Biogene Holding Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,519	5,519	5,539	3,524	2,364	1,552
Revenue Growth	-9.70%	-0.37%	57.17%	49.05%	52.30%	30.41%
Gross Profit	4,433	4,433	4,547	2,947	1,995	1,354
Operating Income	2,121	2,121	2,282	1,612	1,133	910.57
Net Income	1,915	1,915	2,062	1,452	696	808.81
Earnings Per Share	1.81	1.81	2.06	1.48	0.98	0.83
EPS Growth	-18.56%	-12.14%	39.19%	50.83%	18.70%	0.03%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8,329	8,329	5,878	3,790	2,218	7,263
Total Debt	9.69	9.69	6.71	2.73	2.59	-
Net Cash (Debt)	8,319	8,319	5,872	3,787	2,216	7,263
Net Cash Growth	-6.05%	41.68%	55.04%	70.92%	-69.50%	270.86%
Net Cash Per Share	7.85	7.85	5.86	3.85	2.17	7.26

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1,781	1,781	2,041	1,647	931.64	692.4
Capital Expenditures	-428.1	-428.1	-246.77	-226.3	-152.66	-75
Free Cash Flow	1,353	1,353	1,794	1,421	778.97	617.4
Free Cash Flow Growth	-8.24%	-24.63%	26.27%	82.44%	26.17%	-18.62%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	80.34%	80.34%	82.09%	83.63%	84.39%	87.24%
Operating Margin	38.43%	38.43%	41.19%	45.73%	47.92%	58.65%
Pretax Margin	42.59%	42.59%	44.37%	49.52%	49.81%	62.67%
Profit Margin	34.70%	34.70%	37.23%	41.19%	29.44%	52.10%
FCF Margin	24.51%	24.51%	32.40%	40.33%	32.95%	39.77%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	1.405	0.539	0.602	0.440
Dividend Per Share Growth	6.39%	-10.48%	36.84%	-
Dividend Yield	4.57%	1.89%	1.38%	1.49%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	15.28	16.64	22.95	21.73	41.68	-
Forward PE	14.72	12.61	19.66	19.71	26.93	-
P/FCF Ratio	21.71	23.56	26.37	22.19	37.24	-
PS Ratio	5.32	5.78	8.54	8.95	12.27	-